A 52-year-old man from Delhi presents with a 3-month history of epigastric pain relieved by food and antacids. He reports black tarry stools for the past 2 weeks and denies NSAID use. On examination, he appears pale with a blood pressure of 100/65 mmHg and heart rate of 102/min. Hemoglobin is 8.2 g/dL. Upper GI endoscopy reveals a 1.5 cm ulcer on the anterior wall of the duodenum with a visible vessel at the base. H. pylori serology is positive. What is the most likely pathophysiologic mechanism underlying ulcer formation in this patient?

Explanation

## Pathophysiology of H. pylori-Associated Duodenal Ulcer Disease ### Primary Mechanism: Loss of D-Cell Somatostatin → Increased Acid Secretion **Key Point:** In H. pylori-associated **duodenal** ulcer disease, the dominant pathophysiologic mechanism is **increased gastric acid secretion** driven by H. pylori-induced destruction of somatostatin-producing D cells in the antrum. H. pylori colonizes the gastric antrum and causes: 1. **D-cell loss/dysfunction** — Chronic antral inflammation selectively damages somatostatin-producing D cells, removing the principal inhibitory brake on gastrin secretion 2. **Unopposed gastrin release** — Antral G cells secrete excess gastrin (hypergastrinemia) in the absence of somatostatin inhibition 3. **Parietal cell hyperstimulation** — Elevated gastrin drives markedly increased acid output (basal and stimulated) 4. **Duodenal acid overload** — The duodenal mucosa is overwhelmed by excess acid, leading to gastric metaplasia and subsequent H. pylori colonization of the duodenum, culminating in ulceration ### Why Duodenal Ulcers Specifically? **Clinical Pearl:** Duodenal ulcers are characteristically associated with **hyperacidity**, in contrast to gastric ulcers which are more often associated with mucosal defense failure. Studies consistently show that patients with H. pylori-positive duodenal ulcers have significantly elevated basal acid output (BAO) and maximal acid output (MAO) compared to controls. Eradication of H. pylori normalizes acid secretion by restoring somatostatin-mediated inhibition of gastrin — confirming that the acid-secretory axis is the primary driver (Harrison's Principles of Internal Medicine, 21e, Ch. 322). ### Why the Other Options Are Less Correct | Option | Mechanism | Assessment | |--------|-----------|------------| | **A (Correct)** | ↓ D-cell somatostatin → ↑ gastrin → ↑ acid | Primary mechanism in duodenal H. pylori ulcer | | B | ↓ Mucus/HCO₃⁻ | More relevant to NSAID ulcers and gastric H. pylori ulcers | | C | Direct mucosal invasion | H. pylori is non-invasive; it does not penetrate epithelium | | D | Hypochlorhydria → ↑ gastrin | Opposite of what occurs in duodenal ulcer (hyperchlorhydria is the rule) | **High-Yield:** Option C is a common distractor — H. pylori is **not** an invasive organism. It resides in the mucus layer overlying the epithelium and causes damage through urease-generated ammonia, cytotoxins (CagA, VacA), and the resulting inflammatory cascade — but does **not** directly invade epithelial cells. Option A correctly identifies the net result: loss of D-cell somatostatin → hypergastrinemia → hyperacidity → duodenal ulceration. **Key Point:** The classic teaching (Robbins 10e, Ch. 17; KD Tripathi Essentials of Medical Pharmacology) is that H. pylori-associated duodenal ulcers are an **acid-hypersecretory** state mediated by impaired somatostatin inhibition, distinguishing them mechanistically from gastric ulcers where mucosal defense failure predominates. [cite:Harrison's 21e Ch. 322; Robbins 10e Ch. 17]